A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

NCT03882905 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

769

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: Ezetimibe
DRUG: Placebo
DRUG: Simivastatin
DRUG: Statin

Sponsor

Organon and Co